170 related articles for article (PubMed ID: 7972021)
1. Ribozyme-mediated reversal of the multidrug-resistant phenotype.
Scanlon KJ; Ishida H; Kashani-Sabet M
Proc Natl Acad Sci U S A; 1994 Nov; 91(23):11123-7. PubMed ID: 7972021
[TBL] [Abstract][Full Text] [Related]
2. Ribozyme-mediated cleavage of c-fos mRNA reduces gene expression of DNA synthesis enzymes and metallothionein.
Scanlon KJ; Jiao L; Funato T; Wang W; Tone T; Rossi JJ; Kashani-Sabet M
Proc Natl Acad Sci U S A; 1991 Dec; 88(23):10591-5. PubMed ID: 1660142
[TBL] [Abstract][Full Text] [Related]
3. Retrovirus-mediated transfer of anti-MDR1 hammerhead ribozymes into multidrug-resistant human leukemia cells: screening for effective target sites.
Kobayashi H; Takemura Y; Wang FS; Oka T; Ohnuma T
Int J Cancer; 1999 Jun; 81(6):944-50. PubMed ID: 10362143
[TBL] [Abstract][Full Text] [Related]
4. Ribozyme-mediated cleavage of the MDR-1 transcript restores chemosensitivity in previously resistant cancer cells.
Kiehntopf M; Brach MA; Licht T; Petschauer S; Karawajew L; Kirschning C; Herrmann F
EMBO J; 1994 Oct; 13(19):4645-52. PubMed ID: 7925305
[TBL] [Abstract][Full Text] [Related]
5. Reversal MDR in breast carcinoma cells by transfection of ribozyme designed according the secondary structure of mdr1 mRNA.
Gao P; Zhou GY; Zhang QH; Li H; Mu K; Yuan YP; Zhang J; Wang BH
Chin J Physiol; 2006 Apr; 49(2):96-103. PubMed ID: 16830791
[TBL] [Abstract][Full Text] [Related]
6. Modulation of the atypical multidrug-resistant phenotype by a hammerhead ribozyme directed against the ABC transporter BCRP/MXR/ABCG2.
Kowalski P; Stein U; Scheffer GL; Lage H
Cancer Gene Ther; 2002 Jul; 9(7):579-86. PubMed ID: 12082458
[TBL] [Abstract][Full Text] [Related]
7. Reversal of drug sensitivity in multidrug-resistant tumor cells by an MDR1 (PGY1) ribozyme.
Kobayashi H; Dorai T; Holland JF; Ohnuma T
Cancer Res; 1994 Mar; 54(5):1271-5. PubMed ID: 8118816
[TBL] [Abstract][Full Text] [Related]
8. Reversal of HCC drug resistance by using hammerhead ribozymes against multidrug resistance 1 gene.
Qia S; Wang H; Chen X
J Huazhong Univ Sci Technolog Med Sci; 2005; 25(6):662-4. PubMed ID: 16696319
[TBL] [Abstract][Full Text] [Related]
9. Reversal of multiple drug resistance in vitro by phosphorothioate oligonucleotides and ribozymes.
Bertram J; Palfner K; Killian M; Brysch W; Schlingensiepen KH; Hiddemann W; Kneba M
Anticancer Drugs; 1995 Feb; 6(1):124-34. PubMed ID: 7756675
[TBL] [Abstract][Full Text] [Related]
10. Reversion of multidrug resistance in the P-glycoprotein-positive human pancreatic cell line (EPP85-181RDB) by introduction of a hammerhead ribozyme.
Holm PS; Scanlon KJ; Dietel M
Br J Cancer; 1994 Aug; 70(2):239-43. PubMed ID: 7914421
[TBL] [Abstract][Full Text] [Related]
11. mdr1 ribozyme mediated reversal of the multi-drug resistant phenotype in human lung cell lines.
Daly C; Coyle S; McBride S; O'Driscoll L; Daly N; Scanlon K; Clynes M
Cytotechnology; 1996; 19(3):199-205. PubMed ID: 8862007
[TBL] [Abstract][Full Text] [Related]
12. Reversal of P-glycoprotein-mediated multidrug resistance by CD44 antibody-targeted nanocomplexes for short hairpin RNA-encoding plasmid DNA delivery.
Gu J; Fang X; Hao J; Sha X
Biomaterials; 2015 Mar; 45():99-114. PubMed ID: 25662500
[TBL] [Abstract][Full Text] [Related]
13. Reversal of cisplatin resistance in vivo by an anti-fos ribozyme.
Funato T; Ishii T; Kanbe M; Scanlon KJ; Sasaki T
In Vivo; 1997; 11(3):217-20. PubMed ID: 9239514
[TBL] [Abstract][Full Text] [Related]
14. [Mdr-1 ribozyme in the reversal of multidrug resistance in human ovarian cancer].
Yang XK; Xing H; Gao QL; Wang W; Wu SF; Lu YP; Wang SX; Ma D
Zhonghua Zhong Liu Za Zhi; 2003 Sep; 25(5):425-8. PubMed ID: 14575561
[TBL] [Abstract][Full Text] [Related]
15. Differences between drug-sensitive and -resistant human leukemic CEM cells in c-jun expression, AP-1 DNA-binding activity, and formation of Jun/Fos family dimers, and their association with internucleosomal DNA ladders after treatment with VM-26.
Kim R; Beck WT
Cancer Res; 1994 Sep; 54(18):4958-66. PubMed ID: 8069863
[TBL] [Abstract][Full Text] [Related]
16. Reversing multidrug resistance by RNA interference through the suppression of MDR1 gene in human hepatoma cells.
Chen XP; Wang Q; Guan J; Huang ZY; Zhang WG; Zhang BX
World J Gastroenterol; 2006 Jun; 12(21):3332-7. PubMed ID: 16733848
[TBL] [Abstract][Full Text] [Related]
17. Novel approaches to reversing anti-cancer drug resistance using gene-specific therapeutics.
Kobayashi H; Takemura Y; Miyachi H
Hum Cell; 2001 Sep; 14(3):172-84. PubMed ID: 11774737
[TBL] [Abstract][Full Text] [Related]
18. Involvement of extracellular signal-regulated kinase/mitogen-activated protein kinase pathway in multidrug resistance induced by HBx in hepatoma cell line.
Guan J; Chen XP; Zhu H; Luo SF; Cao B; Ding L
World J Gastroenterol; 2004 Dec; 10(23):3522-7. PubMed ID: 15526378
[TBL] [Abstract][Full Text] [Related]
19. Suppression of lung cancer cell growth by ribozyme-mediated modification of p53 pre-mRNA.
Cai DW; Mukhopadhyay T; Roth JA
Cancer Gene Ther; 1995 Sep; 2(3):199-205. PubMed ID: 8528963
[TBL] [Abstract][Full Text] [Related]
20. Reversion of multidrug resistance in the P-glycoprotein positive breast cancer cell line (MCF-7/ADR) by introduction of hammerhead ribozyme.
Yuan Y; Zhang J; Scanlon KJ; Lu Z; Qi G
Chin Med Sci J; 1998 Mar; 13(1):24-8. PubMed ID: 11717919
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
